HDACs may play a main role in carcinogenesis through many pathways, and HDACis can prevent HDAC activity and work as an anticancer strategy by affecting multiple mechanisms inducing cell growth inhibition, cell cycle arrest, apoptosis, and restoration of cilia formation in CCA cells. The gene discussed is HDAC9; the disease is cholangiocarcinoma.